Venture Capital (VC) & Private Funding: Venture investments, while matching Q1 2024 totals at approximately $6.7 billion, showed a clear preference for larger, more developed programs and fewer companies.

In Q2 2025 Leon Precision Capital is focused on robust clinical evidence, efficient operations, and diversified funding strategies to thrive in this evolving environment and capitalize on opportunities that align with long-term growth.

San Francisco, CA – January 15, 2025 – Leon Precision Capital's Angela Jimenez M.D, has been selected to mentor two tech bio and healthcare startups in San Francisco's prestigious Nucleate Program. This highlights our firm's commitment to fostering innovation.

*Image credit: Nucleate

San Francisco, CA – May 14, 2025 – Our investors at Leon Precision Capital, are now mentors for the Stanford Engineering ITRI program. Participating students use AI to personalize drug therapies for resistant bacteria, aiming to save hospitals significant costs. This collaboration highlights our commitment to impactful healthcare innovation, driving the future of precision medicine and economic efficiency in healthcare.

*Image credit: Stanford Engineering